Document:

Exhibit 10.1

 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) THE TYPE THAT THE COMPANY TREATS AS PRIVATE OR CONFIDENTIAL.

 

[***] indicates the
redacted confidential portions of this exhibit.

 

Shareholders’ Undertaking 

relating to 

the Business Combination of 

EnOcean GmbH, Oberhaching, Germany, 

with Parabellum Acquisition Corp.

 

(this “Agreement”)

 

by and between

 

		(1)	EnOcean GmbH, a private limited company incorporated under the laws of Germany with registered seat in Oberhaching, Germany, registered
with the Commercial Register of the Local Court of Munich under HRB 139781, with business address at Kolpingring 18a, 82041 Oberhaching,
Germany,

 

– hereinafter referred
to as the “Company” –

 

		(2)	Parabellum Acquisition Corp., a Delaware corporation, with a business address at 3811 Turtle Creek Blvd., Suite 2125, Dallas,
Texas,

 

– hereinafter referred to as “Parabellum”
 –

 

and

 

		(3)	The shareholders identified in Exhibit A,

 

– each hereinafter referred to as “Shareholder”
and together the “Shareholders” –

 

and

 

	 	(4)	EnOcean Holdings B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) established under
the laws of the Netherlands, registered with the Trade Register held by the Dutch Chamber of Commerce under number 88075885

 

– hereinafter referred to as “Holdco” –

 

The parties
set forth under nos. (1) – (3) above, together with any transferee permitted pursuant to this Agreement, are hereinafter
collectively referred to as the “Parties” and each individually as a “Party”. The terms “Parties“ and “Party“ shall include Holdco with a view to the applicability (solely) of Section 2.2,
Sections 4 through 7, Section 10 and Section 12.

 

Preamble

 

		(A)	The Shareholders, all of whom are listed in Exhibit A, are the sole shareholders of the Company
as of the date of this Agreement holding together more than 95% of the shares in the Company.

 

		(B)	The Company intends to enter into a series of transactions (the “Business Combination”)
with, among other entities, Parabellum, an entity which is listed on the New York Stock Exchange (the “NYSE”), for
purposes of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination as further
described under recital (E) below.

 

		(C)	The Parties are aware that prior to the execution of this Agreement, on 13 November 2022, the Company
                                                                 entered into a business combination agreement with Parabellum and several other entities (the “BCA”) setting
                                                                 forth the terms of the Business Combination. The Parties are in particular aware, and have the common understanding, of the
                                                                 definitions contained in the BCA as also used herein. In connection with the entry into the BCA, certain of the Shareholders entered
                                                                 into a Voting and Shareholder Support Agreement pursuant to which, among other things, they agreed to enter into this
                                                                 Agreement.

 

		(D)	The Company is governed by the articles of association, dated as of April 1, 2015 (“Company
Organizational Documents”) and has entered into that certain Shareholders Agreement 2015, dated as of April 1, 2015, with
all of its current shareholders, as amended (the “Company Shareholder Agreement”). The Company Organizational Documents and the Company
Shareholder Agreement provide for certain transfer restrictions. Each of the Shareholders agrees that it will (i) not exercise any
of such transfer restrictions in connection with the Business Combination and (ii) provide any consent, approval or other action
in order to effect the transfer of Company Shares (as defined below) as foreseen in the BCA to the extent such consent, approval or other
action is required by law, the Company Shareholder Agreement, the Company Organizational Documents and/or any other constitutional or
corporate documents of the Company. For the avoidance of doubt, such transfer restrictions also shall not continue to apply with regards
to ordinary shares in Holdco (“Holdco Ordinary Shares”) following the consummation of the Transactions and the Holdco
Ordinary Shares are not subject to any such transfer restrictions.

 

     

     

    

 

		(E)	Pursuant to the BCA, the Business Combination will, subject to the terms and conditions thereof (including
any amendments, supplements or other modifications thereto in accordance with its terms) and among other transactions contemplated thereby,
be implemented substantially as follows:

 

		(i)	except as otherwise provided for in this Agreement, each of the Shareholders agrees not to sell
                                                               and/or transfer to any third party any of their respective shares held in the Company (“Company Shares”), and
                                                               will contribute their Company Shares to a newly incorporated Dutch corporation in the legal form of a Dutch private limited
                                                               liability company (besloten vennootschap met beperkte aansprakelijkheid) namely Holdco, which will be converted into a Dutch public
                                                               limited liability company at the time and in the manner as set forth in the BCA, in exchange for Holdco Ordinary Shares (the
                                                               “Exchange”), substantially on the basis of the exchange ratio as set forth in the cap table attached hereto as Exhibit B
                                                               (the “Cap Table”, which also illustrates the shareholdings after the implementation of the Business Combination
                                                               and the Exchange);

 

		(ii)	a newly formed and wholly owned
subsidiary of Holdco, incorporated as a Delaware corporation (“Merger Sub”), will be merged with and into Parabellum,
with Parabellum as the surviving company in the merger (the “Surviving Corporation”) and, after giving effect to the
merger: (i) the Surviving Corporation will be a wholly owned subsidiary of Holdco, and (ii) each issued and outstanding share
of Parabellum will be automatically cancelled and extinguished and each holder thereof will be entitled to a claim for a corresponding
share of common stock of the Surviving Corporation that is held in the accounts of the Exchange
Agent, solely for the benefit of the Parabellum Stockholders as immediately prior to the Merger Effective Time; and, immediately
thereafter, (iii) each of the resulting shares of the Surviving Corporation will be exchanged by the Exchange Agent on behalf of
the Parabellum Stockholders (other than holders of Excluded Shares) for one Holdco Ordinary Share (the Exchange and the Business Combination
including the aforementioned transactions under clauses (i) and (ii) and the other transactions contemplated by the BCA, all
as further described in detail in the BCA, collectively the “Transactions”);

 

		(iii)	after giving effect to the Business Combination, the warrants in Parabellum held by the holders thereof
will be converted into a warrant that is exercisable for an equivalent number of Holdco Ordinary Shares (subject to the terms and conditions
of such agreement, as amended); and

 

		(iv)	on or about the Closing Date,
the Holdco Ordinary Shares will be listed on the NYSE or Nasdaq stock exchange. The (pre-closing) equity valuation of the Company,
on the basis of which the Transaction is to be consummated, is USD 120,000,000 (the “Company Equity Value”), which
excludes additional Holdco Ordinary Shares to be issued upon the satisfaction of certain earnout terms and conditions, which would equal
up to fifteen percent (15%) of the total number of outstanding Holdco Ordinary Shares after the consummation of the Transactions.

 

		(F)	It is in the Shareholders’ interest that the Transactions, including for the avoidance of doubt
the Exchange, is implemented substantially as described above and in the BCA.

 

		(G)	In order to facilitate the implementation of the Transaction, each of the Shareholders has duly executed
and delivered or will duly execute and deliver powers of attorney to each of the lawyers, civil-law notaries and notarial employees (advocaten,
(kandidaat-) notarissen en notariële medewerkers) of Dentons Europe LLP in Amsterdam, the Netherlands, and Frankfurt and München,
Germany (the “Dutch POA and the German POA”), permitting the respective authorized person (aa) to execute and deliver
any agreements to which such Shareholder is a party to in connection with the Transactions (including, but not limited to, the Dutch Deeds
of Issue or the German Share Transfer Deed each such term as defined in the BCA), (bb) to take all necessary or desirable actions on behalf
of such Shareholder in connection with the transactions contemplated under and as set forth in the BCA and the Transaction Documents (as
such term is defined in the BCA) to the extent applicable to such Shareholder, (cc) to convene and conduct shareholders’ meetings of the Company (including
participating and exercising voting rights attached to the Company Shares) in accordance with the governing documents of the Company and
for the purpose of obtaining the requisite consent for the Exchange and the other Transactions (including execution of Transaction Documents)
and (dd) to support the transactions contemplated by the BCA and the other Transaction Documents (including by way of waiving any restrictions
on the sale, disposition or transfer of the Company Shares held by such Shareholder).

 

    2 

     

    

 

NOW, THEREFORE,
the Parties hereby enter into this Agreement and agree as follows:

 

		1.	[Remains empty.]

 

		2.	Undertakings of the Shareholders.

 

		2.1.	Each
Shareholder hereby irrevocably and unconditionally undertakes and agrees, vis-à-vis Holdco and Parabellum, and in each case to
the extent legally possible and permissible:

 

		2.1.1.	to fully support the Transactions and to implement the Transactions contemplated under and as set forth
in the BCA and the other Transaction Documents in relation to which the Shareholders support or participation is required or appropriate,
and in particular, without limitation, to:

 

		(a)	enter into, amend, restate and/or terminate any and all agreements as contemplated herein or therein and
required, necessary or appropriate in this context;

 

		(b)	make and accept any and all declarations (including approvals and waivers of any kind, including waiving
rights of first refusal and similar rights) which are necessary or appropriate in this context;

 

		(c)	if and when shareholders’ meetings of the Company are held, appear at such meetings (in person or
through a representative) and cause the Company Shares to be counted as present thereat for the purpose of establishing a quorum;

 

		(d)	participate in shareholders’ meetings of the Company and vote in favor of and pass any and all resolutions
therein which are necessary or appropriate in this context, it being understood and agreed that, in particular, without limitation, each
Shareholder shall participate in, vote in favor of and pass any and all resolutions with respect to the approval of the transfer of Company
Shares to Holdco within the Exchange (the “Shareholder Resolutions”);

 

		(e)	to cause and instruct the members of the advisory board of the Company (Gesellschafterausschuss)
to vote in favor of all consents and approvals required by the advisory board to support and implement the Transaction and the transactions
contemplated under and as set forth in the BCA and the other Transaction Documents in particular, without limitation, the approval of
the transfer of Company Shares to Holdco within the Exchange; and

 

		(f)	do any and all other acts of any kind which are necessary or appropriate to implement the Business Combination,
when requested by the Company.

 

    3 

     

    

 

		2.1.2.	to refrain from taking any actions which could be detrimental to, impede, interfere with, prohibit, delay,
postpone or otherwise adversely affect the implementation or completion of the transactions contemplated by and as set forth in the BCA
or the other Transaction Documents, including the Transactions, in particular, without limitation, (i) except for the Exchange or
as otherwise provided for herein, not to sell, transfer, pledge, encumber, assign, hedge, swap, convert or otherwise dispose of (including
by merger (including conversion into securities or other consideration), by tendering into any tender or exchange offer, by testamentary
disposition, by operation of Law or otherwise), either voluntarily or involuntarily, or establish or increase a put equivalent position
or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to (collectively,
 “Transfer”), or enter into any Contract or option with respect to the Transfer of, any of the Company Shares or other
Equity Interests of the Company held by such Shareholder, whether acquired prior to, on or after the date hereof, (ii) not to withdraw
(or request withdrawal) from this Agreement, and (iii) not to enter into any voting agreement or voting trust, or grant a proxy or
power of attorney, that (a) is inconsistent with its obligations pursuant to this Agreement; (b) could result in the failure
of any condition set forth in the BCA to be satisfied; or (c) could result in a breach of any undertaking, representation or warranty
of such Shareholder contained in this Agreement;

 

		2.1.3.	to the extent not already duly executed and delivered, to duly execute (with a wet-ink signature) and
deliver to the Company the Dutch POA and the German POA and to have the Dutch POA and the German POA notarized, apostilled and, as applicable,
accompanied by a confirmation attached as an annex to the Dutch POA and the German POA in accordance with the instructions listed underneath
the signature block to the Dutch POA and the German POA; and

 

		2.1.4.	to, in particular, (i) contribute his, her or its Company Shares to Holdco in exchange for Holdco
Ordinary Shares substantially in accordance with the Cap Table and as contemplated in the BCA and (ii) duly execute the German Share
Transfer Deed.

 

	 	2.2.	Each Shareholder hereby transfers to Holdco (who accepts such transfer) any and all Company Shares the respective Shareholder holds now
or at the time of Closing subject to the sole condition precedent (aufschiebend bedingt) that the Dutch Deed of Issue (as referred to
in Section 2.01(a) of the BCA) has been notarized. The Parties hereby irrevocably instruct the acting notary public to file an updated
list of shareholders upon confirmation (email sufficient) that the condition precedent has occurred, substantially in the form attached
hereto as Exhibit C, to be signed by the current CEO (Mr. Raoul Wijgergangs) or any future managing director of the Company. The acting
notary public shall be under no obligation to verify the content of the confirmation.
	 	 	 
		2.3.	Without prejudice to the Exchange (being qualified as a capital increase of the share capital of Holdco
against contribution in kind), the undertakings and agreements of a Shareholder set out above in Section 2.1 shall not constitute
any funding or capital contribution obligation of such Shareholder.

 

		2.4.	Notwithstanding Section 2.1.2 above, a Shareholder may prior to the Exchange, Transfer its Company
Shares to a party that is or becomes a party to this Agreement and bound by the terms and obligations hereof provided that the Company
shall not permit the transfer of any Company Shares held by a Shareholder on its books, and such transfer shall not become effective,
unless and until the person to whom such Company Shares are to be transferred shall have executed this Agreement or a joinder in form
and substance reasonably acceptable to the Company, pursuant to which such person becomes a party to this Agreement and agrees to be bound
by all the provisions hereof as if such person were a Shareholder at inception of this Agreement,

 

		3.	Waiver of Rights. Each Shareholder hereby agrees to waive the application of any and all
                                                                                                                                            rights of first refusal, right of first offer, co-sale rights, or other protective provisions granted, and any notice provisions
                                                                                                                                            that may be applicable to the transfer of any Shares, under the Company Organizational Documents and the Company Shareholder
                                                                                                                                            Agreement unless such right (such as a drag-right under the Company Shareholder Agreement) only serves to facilitate the Exchange.

 

		4.	Costs and Expenses. Except as otherwise provided for in this Agreement or by way of bilateral agreement
among any of the parties of the Transactions (for the avoidance of doubt, with binding effect only for such parties), all costs, including
fees and expenses, incurred in connection with the preparation, negotiation, execution and consummation of this Agreement or the transactions
contemplated herein, including, without limitation, the costs of professional advisers, shall be borne by the Party that incurred such
costs. The notarial costs for the recording and execution of this Agreement and its exhibits, (including the aforementioned Dutch POA
and the German POA and the notarization thereof), shall be borne by the Company.

 

		5.	No Assignment of Rights and Obligations. No rights and/or obligations under this Agreement can be transferred or assigned in
whole or in part without the prior written consent of the other Parties. However, the transferring Party shall remain liable in addition
to the entering party for its obligations arising out of this Agreement.

 

		6.	Terms of this Agreement; Termination of Prior Agreements.

 

		6.1.	This Agreement shall have effect as from the date of its notarization by each Party up to the earlier
of (i) the expiry of the Outside Date as defined in the BCA (ii) the termination of the BCA in accordance with its terms or
(iii) the consummation of all transactions contemplated under the BCA, and any other right to leave or terminate this Agreement for
any other reason shall be excluded to the extent legally possible.

 

    4 

     

    

 

		6.2.	The termination of this Agreement in accordance with Section 6.1 shall be without
                                                                                                                                                   prejudice to (i) Section 2.2 in case of Section 6.1(iii) and (ii) any claims against a Shareholder that is in breach of this
                                                                                                                                                   Agreement in any respect as of the time of the effectiveness of such termination and, for the avoidance of doubt, the Company or
                                                                                                                                                   Holdco, as applicable, and Parabellum shall, without limiting any other rights or remedies relating thereto, have the right to
                                                                                                                                                   enforce such claims against such Shareholder notwithstanding such termination. Notwithstanding the foregoing or anything to the
                                                                                                                                                   contrary herein, in no event shall Parabellum have any obligation or liability of any kind or to any person by reason of being party
                                                                                                                                                   to or enforcing any of its rights under this Agreement.

 

		7.	Confidentiality. Neither the Shareholders, nor any of their respective affiliates, shall make any
public announcement or issue any public communication regarding this Agreement or the BCA or the transactions contemplated hereby or thereby,
or any matter related to the foregoing, without first obtaining the prior consent of Parabellum (which consent shall not be unreasonably
withheld, conditioned or delayed), except if such announcement or other communication is required by applicable law or legal process (including
pursuant to the securities laws or the rules of any national securities exchange), in which case the applicable Party shall use commercially
reasonable efforts to obtain such consent with respect to such announcement or communication from Parabellum prior to announcement or
issuance.

 

		8.	Termination of Certain Agreements. The Company and each of the Shareholders hereby acknowledge
and agree that the Company Shareholder Agreement shall, contingent upon the approval of the requisite parties and the occurrence of the
Closing, terminate and be of no force and effect effective immediately prior to the Effective Time, and each of the Shareholders hereby
agrees to the waiver of any rights thereunder in connection with the transactions contemplated by the BCA.

 

		9.	Standstill. From the date of this Agreement until the termination of this Agreement in accordance
with Section 6, none of the Shareholders shall engage in any transaction involving the securities of Parabellum without Parabellum’s
prior written consent (which consent shall not be unreasonably, withheld, conditioned, or delayed).

 

		10.	Disclosure. Each Shareholder hereby authorizes the Company, Holdco and Parabellum to publish and
disclose in any announcement or disclosure required by applicable securities Laws or the SEC or any other securities authorities or any
other documents or communications provided by Parabellum, Holdco or the Company to any Governmental Authority or to securityholders of
Parabellum, such Shareholder’s identity and ownership of the Company Shares, a copy of this Agreement, and the nature of such Shareholder’s
obligations under this Agreement. Each Shareholder will promptly provide any information reasonably requested by Parabellum, Holdco or
the Company for any regulatory application or filing made or approval sought in connection with the transactions contemplated by the BCA
(including filings with the SEC).

 

		11.	Representations and Warranties; Liability.

 

		11.1.	Each
Shareholder hereby warrants as individual debtor (als Einzelschuldner) and under exclusion of any joint and several liability
(unter Ausschluss gesamtschuldnerischer Haftung) vis-à-vis Holdco and Parabellum by way of an independent warranty that
(i) upon execution of this Agreement on the date of its notarization by such Shareholder, and (ii) immediately prior to the
consummation of the Exchange, the following statements are true and accurate, in each case however solely with respect to the respective
Shareholder (and for the avoidance of doubt, not for any of the other Shareholders) and the Company Shares held by him, her or it:

 

		11.1.1.	Ownership. Such Shareholder has (i) sole and exclusive legal and beneficial ownership of,
(ii) good and valid title to and (iii) full and exclusive power to vote with, in each case, the Company Shares set forth next
to his, her or its name on the Cap Table (as supplemented). Each of its Company Shares have been fully paid in and not been repaid. Other
than this Agreement, the BCA or the other Transaction Documents and save for (as the case may be) the Company Shareholder Agreement and
the Pool Agreement dated May 6, 2008 (as amended from time to time) (the “Pool Agreement”), (a) there are no agreements
or arrangements of any kind, contingent or otherwise, to which such Shareholder is a party obligating such Shareholder to transfer or
cause to be transferred to any person other than Holdco any of his, her or its Company Shares, (b) no person other than Holdco has
any contractual or other right or obligation to purchase or otherwise acquire any of such Shareholder’s Company Shares, (c) such
Shareholder is not a party to any voting trust, proxy or other agreement or arrangement with respect to the voting of such Shareholder’s
Company Shares, (d) there are no security interests, liens, pledges or other encumbrances or third party rights on such Shareholder’s
Company Shares, (e) such Shareholder’s Company Shares are not subject to any transfer restrictions or pre-emption or similar
acquisition rights other than as provided for by the Company Organizational Documents (including the articles of association of the Company),
the Company Shareholder Agreement and the Pool Agreement (as the case may be) or this Agreement, and (f) such Shareholder’s
Company Shares are not subject to any trust agreements or sub-participations. Except as substantially set forth in the Cap Table such
Shareholder does not hold any Equity Interests (as such term is defined in the BCA) in the Company or its subsidiaries.

 

    5 

     

    

 

		11.1.2.	Authority; Enforceability. Such Shareholder has (subject to the waiver by the respective Shareholder
and all other Shareholders of all transfer restrictions contained in the Company Shareholder Agreement and the Company Organizational
Documents) full power and authority and is duly authorized to make, enter into and carry out the terms of this Agreement and to perform
its obligations hereunder. This Agreement has been duly and validly executed and delivered by each Shareholder and constitutes a valid
and binding agreement of such Shareholder, enforceable against the Shareholder in accordance with its terms.

 

		11.1.3.	No Violation. The execution, delivery and performance of this Agreement by such Shareholder will
not (a) violate any provision of any law applicable to such Shareholder or any of his, her or its Company Shares; (b) violate
any order, judgment or decree applicable to such Shareholder or any of its Company Shares; (c) result in the creation of any lien
or encumbrance upon any of its Company Shares; or (d) conflict with, or result in a breach or default under, any agreement or instrument
to which a Shareholder is a party or by which or any of its Company Shares are bound (subject to the waiver by the respective Shareholder
and all other Shareholders of all transfer restrictions contained in the Company Shareholder Agreement and the Company Organizational
Documents); except where, in each of the cases (a) through (d), such violation or conflict would not reasonably be expected to have,
individually or in the aggregate, (a) a material impact on such Shareholder’s ownership of its Company Shares or (b) a
material adverse effect on the ability of such Shareholder to satisfy or perform any of such Shareholder’s covenants and obligations
hereunder.

 

		11.1.4.	No Spousal Consent. Such Shareholder does not, under applicable law, require the consent of his
or her spouse to any of the contemplated Transactions.

 

		11.1.5.	Consents and Approvals. The execution and delivery by such Shareholder of this Agreement does not,
and the performance of such Shareholder’s covenants and obligations hereunder do not, require such Shareholder to obtain any consent,
approval, authorization or permit of, or to make any filing with or notification to, any person or entity.

 

		11.1.6.	Litigation. There is no proceeding pending or threatened against such Shareholder or his, her or
its Company Shares which has had or could reasonably be expected to have, individually or in the aggregate, (i) a material impact
on such Shareholder’s ownership of its Company Shares or (ii) a material adverse effect on the ability of such Shareholder
to perform any of such Shareholder’s covenants and obligations hereunder.

 

		11.1.7.	No Insolvency. No petitions to commence bankruptcy or insolvency proceedings concerning such Shareholder
have been filed, nor have any such proceedings been commenced. To such Shareholder’s best knowledge, no circumstances exist that
would require a petition for any bankruptcy, insolvency or judicial composition proceedings, nor do any circumstances exist which according
to any applicable bankruptcy, insolvency or creditor rights laws, would justify an action to void (Anfechtung) this Agreement.

 

		11.2.	Any and all obligations of a Shareholder under this Agreement shall be undertaken by such Shareholder
solely as individual debtor (als Einzelschuldner) and under exclusion of any joint and several liability (unter Ausschluss gesamtschuldnerischer
Haftung) and solely with respect to the respective Company Shares held by such Shareholder.

 

    6 

     

    

 

		11.3.	Each Shareholder’s liability for any and all claims of Holdco and Parabellum under or in connection
with this Agreement shall be limited to an aggregate maximum amount of such Shareholder’s pro rata participation (based on the ratio
of its participation in the share capital of the Company immediately prior to the Exchange) in the Company Equity Value.

 

		11.4.	The claims of Holdco and Parabellum under or in connection with this Section 11 shall become time-barred
two (2) years after the date of notarization of this Agreement.

 

		12.	Miscellaneous.

 

		12.1.	This Agreement and its exhibits and the documents contemplated hereby and thereby comprise the entire
agreement between all of the Parties concerning its subject matter and shall supersede all prior agreements, oral and written declarations
of intent and other arrangements (whether binding or non-binding) made by the Parties in respect thereof, except for any further agreements
entered into in connection with the Transaction (in particular: the Transaction Documents).

 

		12.2.	Any notice or other declaration to be given to any Shareholder (i) in his, her or its position as
a shareholder of the Company (e.g. invitations to shareholders’ meetings) or (ii) under this Agreement shall and may be sent
to the correspondence address and/or e-mail address as set forth in Exhibit D. Each Shareholder shall be obliged to inform
the Company in writing of any change of his, her or its respective correspondence address and/or e-mail address, as the case may be, without
undue delay.

 

		12.3.	All exhibits to this Agreement shall form an integral part of this Agreement. In case of a conflict between
any exhibit and the provisions of this Agreement, the provisions of this Agreement shall prevail.

 

		12.4.	The headings in this Agreement are inserted for convenience only and shall not affect the interpretation
of this Agreement.

 

		12.5.	Amendments, additions or modifications to this Agreement, including this Section 12.5, shall
be valid only if made in writing unless a stricter form is prescribed by mandatory law and, in each such case, shall require the prior
written consent of Parabellum.

 

		12.6.	If any court of competent jurisdiction holds any provision of this Agreement invalid or unenforceable,
the other provisions of this Agreement shall remain in full force and effect. The invalid or unenforceable provision shall be deemed to
have been replaced by a valid, enforceable and fair provision which comes as close as possible to the intentions of the Parties hereto
at the time of the conclusion of this Agreement. The same shall apply in case of any unintended gaps. It is the express intent of the
Parties that the validity and enforceability of all other provisions of this Agreement shall be maintained and that this Section 12.6
shall not result in a reversal of the burden of proof but that Section 139 German Civil Code is hereby excluded in its entirety.

 

		12.7.	It is the Parties joint understanding that this Agreement and its interpretation and any
                                                                                                                                                    non-contractual obligations in connection with it are subject to German substantive law. 

 

		12.8.	English language terms used in this Agreement describe German legal concepts only and shall not be interpreted
by reference to any meaning attributed to them in any jurisdiction other than Germany. Where a German term has been inserted in brackets
and/or italics it alone (and not the English term to which it relates) shall be authoritative for the purpose of the interpretation of
the relevant term whenever it is used in this Agreement.

 

		12.9.	Exclusive place of jurisdiction for all disputes regarding rights and duties under this Agreement, including its validity shall, to
the extent legally permissible, be Oberhaching.

 

[Signature Page Follows]

 

    7 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have hereunto caused this Agreement to be duly executed as of the date hereof.

 

		PARABELLUM:
	 	 
	 	PARABELLUM ACQUISITION CORP.
	 	 	 
	 	By: 	/s/ Narbeh Derhacobian
	 	Name:	Narbeh Derhacobian
	 	Title:	Chief Executive Officer and President
	 	 	 
	 	COMPANY:
	 	 
	 	enocean gmbh
	 	 	 
	 	 By:	/s/ Raoul Wijgergangs
	 	Name:	Raoul Wijgergangs
	 	Title:	Chief Executive Officer
	 	 	 
	 	HOLDCO:
	 	 	 
	 	ENOCEAN B.V.
	 	 
	 	By:	/s/ Raoul Wijgergangs
	 	Name:	Raoul Wijgergangs
	 	Title:	 Managing Director
	 	 	 
	 	SHAREHOLDERS:
	 	 
	 	By:	[***]

 

[Signature Page to Shareholders’ Undertaking]

 

     

     

    

 

Exhibit A 

List of Shareholders

 

(holding more than 95%
of the shares in the Company) 

 

[***]

 

 

 

 

 

 

 

    [Exhibit A to Shareholders’ Undertaking]

     

    

 

Exhibit B 

Cap Table

 

 

 

 

 

 

 

    [Exhibit B to Shareholders’ Undertaking]

     

    

 

Exhibit C 

Draft Confirmation to Notary

Cap Table

 

Email, fax or letter from
a managing director of EnOcean GmbH stating:

 

“I hereby
confirm, with a view to the condition precedent set forth in Section 2.2 of the Shareholder Undertaking notarized on 20 December
2022 (notarial deed No. [***]/2022 of notary public Dr. Silke Gantzckow with office seat in Frankfurt am Main, Germany), that the
Dutch Deed of lssue (as referred to in Section 2.2 of the Shareholder Undertaking) has been notarized today.”

 

 

 

 

 

 

 

    [Exhibit C to Shareholders’ Undertaking]

     

    

 

Exhibit D 

Notices

 

[***]

 

 

 

 

 

 

 

    [Exhibit D to Shareholders’ Undertaking]exhibit
10.1

 

Securities
Purchase Agreement

 

This
Securities Purchase Agreement (this “Agreement”),
dated as of December 19, 2022, is entered into by and between China SXT Pharmaceuticals, Inc.,
a British Virgin Islands corporation (“Company”), and Streeterville
Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).

 

A.   Company
and Investor are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the Securities
Act of 1933, as amended (the “1933 Act”), and the rules and regulations promulgated thereunder by the United States
Securities and Exchange Commission (the “SEC”).

 

B.   Investor
desires to purchase and Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a Convertible Promissory
Note (the “Note”),, in the form attached hereto as Exhibit A, in the original principal amount of $1,595,000.00
(the “Initial Principal Balance”), convertible into ordinary shares, $0.004 par value per share, of Company (the “Ordinary
Shares”), upon the terms and subject to the limitations and conditions set forth in such Note.

 

C.   This
Agreement, the Note, and all other certificates, documents, agreements, resolutions and instruments delivered to any party under or in
connection with this Agreement, as the same may be amended from time to time, are collectively referred to herein as the “Transaction
Documents”.

 

D.   For
purposes of this Agreement: “Conversion Shares” means all Ordinary Shares issuable upon conversion of all or any portion
of the Note; and “Securities” means the Note and the Conversion Shares.

 

NOW,
THEREFORE, in consideration of the above recitals and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, Company and Investor hereby agree as follows:

 

1.   Purchase
and Sale of Securities.

 

1.1.   Purchase
of Securities. Company shall issue and sell to Investor and Investor shall purchase from Company the Note. In consideration thereof,
Investor shall pay the Purchase Price (as defined below) to Company.

 

1.2.   Form
of Payment. On the Closing Date (as defined below), Investor shall wire the Purchase Price in immediately available funds to a bank
account designated by Company against delivery of the Note.

 

1.3.   Closing
Date. Subject to the satisfaction (or written waiver) of the conditions set forth in Section 5 and Section 6 below, the closing of
the transactions contemplated by this Agreement (the “Closing”) shall be no later than December 19, 2022 (the “Closing
Date”), or another mutually agreed upon date. The Closing shall occur on the Closing Date by means of the exchange by email
of signed .pdf documents, but shall be deemed for all purposes to have occurred at the offices of Hansen Black Anderson Ashcraft PLLC
in Lehi, Utah.

 

1.4.   Collateral
for the Note. The Note shall be unsecured.

 

     

     

    

 

1.5.
Original Issue Discount; Transaction Expense Amount. The Note carries an original issue discount of $95,000.00 (the “OID”).
In addition, Company agrees to pay $20,000.00 to Investor to cover Investor’s legal fees, accounting costs, due diligence, monitoring
and other transaction costs incurred in connection with the purchase and sale of the Securities (the “Transaction Expense Amount”).
The Transaction Expense Amount will be reduced from the amount funded at Closing. The “Purchase Price”, therefore,
shall be $1,500,000.00, computed as follows: $1,595,000.00 Initial Principal Balance, less the OID.

 

2.   Investor’s
Representations and Warranties. Investor represents and warrants to Company that as of the Closing Date: (i) this Agreement has been
duly and validly authorized; (ii) this Agreement constitutes a valid and binding agreement of Investor enforceable in accordance with
its terms; and (iii) Investor is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D of the 1933
Act.

 

3.   Company’s
Representations and Warranties. Company represents and warrants to Investor that as of the Closing Date: (i) Company is a corporation
duly organized, validly existing and in good standing under the laws of its state of incorporation and has the requisite corporate power
to own its properties and to carry on its business as now being conducted; (ii) Company is duly qualified as a foreign corporation to
do business and is in good standing in each jurisdiction where the nature of the business conducted or property owned by it makes such
qualification necessary; (iii) Company has registered its Ordinary Shares under Section 12(b) of the Securities Exchange Act of
1934, as amended (the “1934 Act”), and is obligated to file reports pursuant to Section 13 or Section 15(d)
of the 1934 Act; (iv) each of the Transaction Documents and the transactions contemplated hereby and thereby, have been duly and validly
authorized by Company and all necessary actions have been taken; (v) this Agreement, the Note, and the other Transaction Documents have
been duly executed and delivered by Company and constitute the valid and binding obligations of Company enforceable in accordance with
their terms; (vi) the execution and delivery of the Transaction Documents by Company, the issuance of Securities in accordance with the
terms hereof, and the consummation by Company of the other transactions contemplated by the Transaction Documents do not and will not
conflict with or result in a breach by Company of any of the terms or provisions of, or constitute a default under (a) Company’s
formation documents or bylaws, each as currently in effect, (b) any indenture, mortgage, deed of trust, or other material agreement or
instrument to which Company is a party or by which it or any of its properties or assets are bound, including, without limitation, any
listing agreement for the Ordinary Shares, or (c) any existing applicable law, rule, or regulation or any applicable decree, judgment,
or order of any court, United States federal, state or foreign regulatory body, administrative agency, or other governmental body having
jurisdiction over Company or any of Company’s properties or assets; (vii) no further authorization, approval or consent of any
court, governmental body, regulatory agency, self-regulatory organization, or stock exchange or market or the stockholders or any lender
of Company is required to be obtained by Company for the issuance of the Securities to Investor or the entering into of the Transaction
Documents; (viii) none of Company’s filings with the SEC contained, at the time they were filed, any untrue statement of a material
fact or omitted to state any material fact required to be stated therein or necessary to make the statements made therein, in light of
the circumstances under which they were made, not misleading; (ix) Company has filed all reports, schedules, forms, statements and other
documents required to be filed by Company with the SEC under the 1934 Act on a timely basis or has received a valid extension of such
time of filing and has filed any such report, schedule, form, statement or other document prior to the expiration of any such extension;
(x) there is no action, suit, proceeding, inquiry or investigation before or by any court, public board or body pending or, to the knowledge
of Company, threatened against or affecting Company before or by any governmental authority or non-governmental department, commission,
board, bureau, agency or instrumentality or any other person, wherein an unfavorable decision, ruling or finding would have a material
adverse effect on Company or which would adversely affect the validity or enforceability of, or the authority or ability of Company to
perform its obligations under, any of the Transaction Documents; (xi) Company has not consummated any financing transaction that has
not been disclosed in a periodic filing or current report with the SEC under the 1934 Act; (xii) Company is not, nor has it been at any
time in the previous twelve (12) months, a “Shell Company,” as such type of “issuer” is described in Rule 144(i)(1)
under the 1933 Act; (xiii) with respect to any commissions, placement agent or finder’s fees or similar payments that will or would
become due and owing by Company to any person or entity as a result of this Agreement or the transactions contemplated hereby (“Broker
Fees”), any such Broker Fees will be made in full compliance with all applicable laws and regulations and only to a person
or entity that is a registered investment adviser or registered broker-dealer; (xiv) Investor shall have no obligation with respect to
any Broker Fees or with respect to any claims made by or on behalf of other persons for fees of a type contemplated in this subsection
that may be due in connection with the transactions contemplated hereby and Company shall indemnify and hold harmless each of Investor,
Investor’s employees, officers, directors, stockholders, members, managers, agents, and partners, and their respective affiliates,
from and against all claims, losses, damages, costs (including the costs of preparation and attorneys’ fees) and expenses suffered
in respect of any such claimed Broker Fees; (xv) neither Investor nor any of its officers, directors, stockholders, members, managers,
employees, agents or representatives has made any representations or warranties to Company or any of its officers, directors, employees,
agents or representatives except as expressly set forth in the Transaction Documents and, in making its decision to enter into the transactions
contemplated by the Transaction Documents, Company is not relying on any representation, warranty, covenant or promise of Investor or
its officers, directors, members, managers, employees, agents or representatives other than as set forth in the Transaction Documents;
(xvi) Company acknowledges that the State of Utah has a reasonable relationship and sufficient contacts to the transactions contemplated
by the Transaction Documents and any dispute that may arise related thereto such that the laws and venue of the State of Utah, as set
forth more specifically in Section 9.2 below, shall be applicable to the Transaction Documents and the transactions contemplated therein;
(xvii) Company has notified Nasdaq of its intention to be subject to the home country practice of the British Virgin Islands, has made
all applicable filings with the SEC with respect to relying on home country practice and thus Nasdaq Listing Rule 5635(d) does not apply
to Company; (xviii) Company has consulted with counsel and conducted its own due diligence, and understands that Investor is not registered
as a ‘dealer’ under the 1934 Act, and agrees that the parties’ performance of the obligations under the Transaction
Documents and the transactions contemplated by the Transaction Documents do not violate Section 15 of the 1934 Act or any other applicable
securities laws; and (xix) Company has performed due diligence and background research on Investor and its affiliates and has received
and reviewed the due diligence packet provide by Investor. Company, being aware of the matters and legal issues described in subsections
(xviii) and (xix) above, acknowledges and agrees that such matters, or any similar matters, have no bearing on the transactions contemplated
by the Transaction Documents and covenants and agrees it will not use any such information or legal theory as a defense to performance
of its obligations under the Transaction Documents or in any attempt to avoid, modify, reduce, rescind or void such obligations.

 

    2

     

    

 

4.   Company
Covenants.

 

4.1.   Until
all of Company’s obligations under all of the Transaction Documents are paid and performed in full, Company will at all times comply
with the following covenants: (i) so long as Investor beneficially owns any of the Securities and for at least twenty (20) Trading Days
(as defined in the Note) thereafter, Company will timely file on the applicable deadline all reports required to be filed with the SEC
pursuant to Sections 13 or 15(d) of the 1934 Act, and will take all reasonable action under its control to ensure that adequate
current public information with respect to Company, as required in accordance with Rule 144 of the 1933 Act, is publicly available, and
will not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations
thereunder would permit such termination; (ii) when issued, the Conversion Shares will be duly authorized, validly issued, fully paid
for and non-assessable, free and clear of all liens, claims, charges and encumbrances; (iii) the Ordinary Shares shall be listed or quoted
for trading on NYSE or Nasdaq; (iv) trading in Company’s Ordinary Shares will not be suspended, halted, chilled, frozen, reach
zero bid or otherwise cease trading on Company’s principal trading market; (v) Company will not make any Variable Security Issuances
(as defined below) without Investor’s prior written consent, which consent may be granted or withheld in Investor’s sole
and absolute discretion; (vi) Company shall not enter into any agreement or otherwise agree to any covenant, condition, or obligation
that locks up, restricts in any way or otherwise prohibits Company: (a) from entering into a variable rate transaction with Investor
or any affiliate of Investor, or (b) from issuing Ordinary Shares, preferred stock, warrants, convertible notes, other debt securities,
or any other Company securities to Investor or any affiliate of Investor; and (vii) Company hereby grants to Investor a participation
right, whereby Investor shall have the right to participate in Investor’s discretion in up to thirty percent (30%) of the amount
raised in any equity or debt financing of Company to any U.S. Person as defined in Regulation S of the Securities Act in the U.S. In
furtherance thereof, should Company seek to raise capital via any transaction covered by the foregoing participation right it shall provide
Investor written notice of such proposed transaction, along with copies of the proposed transaction documents. Investor shall then have
up to two (2) calendar days to elect to purchase up to thirty percent (30%) of the securities proposed to be issued in such transaction
on the most favorable terms and conditions offered to any other purchaser of the same securities. The parties agree that in the event
Company breaches the covenant set forth in Section 4(vii) above, Investor’s sole and exclusive remedy shall be to receive, as liquidated
damages, an amount equal to twenty percent (20%) of the amount Investor would have been entitled to invest under the participation right,
which may be added to the Outstanding Balance (as defined in the Note) of the Note if not otherwise paid in cash by Company. For
purposes hereof, the term “Variable Security Issuance” means any issuance of any Company securities that (A) have
or may have conversion rights of any kind, contingent, conditional or otherwise, in which the number of shares that may be issued pursuant
to such conversion right varies with the market price of the Ordinary Shares, or (B) are or may become convertible into Ordinary Shares
(including without limitation convertible debt, warrants or convertible preferred stock), with a conversion price that varies with the
market price of the Ordinary Shares, even if such security only becomes convertible following an event of default, the passage of time,
or another trigger event or condition. For avoidance of doubt, the issuance of Ordinary Shares under, pursuant to, in exchange for or
in connection with any contract or instrument, whether convertible or not, is deemed a Variable Security Issuance for purposes hereof
if the number of Ordinary Shares to be issued is based upon or related in any way to the market price of the Ordinary Shares, including,
but not limited to, Ordinary Shares issued in connection with a Section 3(a)(9) exchange, a Section 3(a)(10) settlement, or any other
similar settlement or exchange. For the further avoidance of doubt, Ordinary Share issued pursuant to an ATM facility or a primary offering
with no variable pricing features will not be considered to be a Variable Security Issuance.

 

4.2.   Until
the earlier of the date that is six (6) months from the Closing Date and the date that Company has filed one (1) or more prospectus supplement(s)
relating to the sale of up to the Initial Principal Balance of Conversion Shares as defined in the Note (“Registration Obligation
End Date”), Company will immediately, but in no event later than three (3) Trading Days after at least $100,000.00 in space
under the Shelf becomes available, file a prospectus supplement to its registration statement on Form F-3 (No. 333-252664) (the “Shelf”)
each time at least $100,000.00 of space under the Shelf becomes available. In any event, Company will have caused at least one prospectus
supplement to be filed under this Section 4.2 on or before March 24, 2023. By way of example only, in the event Company had $300,000
in available issuance capacity under the Shelf on January 10, 2023, it would immediately, but in no event later than three (3) Trading
Days after space under the Shelf becomes available, file a prospectus supplement registering the sale of up to $300,000.00 of Conversion
Shares for Investor. If on January 30, 2023 Company had $200,000.00 in available issuance capacity under the Shelf, Company would immediately,
but in no event later than three (3) Trading Days after space under the Shelf becomes available, file a prospectus supplement registering
the sale of up to $200,000.00 of Conversion Shares for Investor. The obligation to continue filing prospectus supplements will continue
until the Registration Obligation End Date.

 

    3

     

    

 

5.   Conditions
to Company’s Obligation to Sell. The obligation of Company hereunder to issue and sell the Securities to Investor at the Closing
is subject to the satisfaction, on or before the Closing Date, of each of the following conditions:

 

5.1.   Investor
shall have executed this Agreement and delivered the same to Company.

 

5.2.   Investor
shall have delivered the Purchase Price to Company in accordance with Section 1.2 above.

 

6.   Conditions
to Investor’s Obligation to Purchase. The obligation of Investor hereunder to purchase the Securities at the Closing is subject
to the satisfaction, on or before the Closing Date, of each of the following conditions, provided that these conditions are for Investor’s
sole benefit and may be waived by Investor at any time in its sole discretion:

 

6.1.   Company
shall have executed this Agreement and the Note and delivered the same to Investor.

 

6.2.   Company
shall have delivered to Investor a fully executed Irrevocable Letter of Instructions to Transfer Agent (the “TA Letter”)
substantially in the form attached hereto as Exhibit B acknowledged and agreed to in writing by Company’s transfer agent
(the “Transfer Agent”).

 

6.3.   Company
shall have delivered to Investor a fully executed Officer’s Certificate substantially in the form attached hereto as Exhibit
C evidencing Company’s approval of the Transaction Documents.

 

In
the event any of the conditions in Sections 5 and 6 is not satisfied or waived by the Closing Date, the Agreement will be cancelled and
deemed void ab initio.

 

7.   Reservation
of Shares. On the date hereof, Company will reserve 10,000,000 Ordinary Shares from its authorized and unissued Ordinary Shares to
provide for all issuances of Ordinary Shares under the Note (the “Share Reserve”). Company further agrees to add additional
Ordinary Shares to the Share Reserve in increments of 1,000,000 shares as and when requested by Investor if as of the date of any such
request the number of shares being held in the Share Reserve is less than three (3) times the number of Ordinary Shares obtained by dividing
the Outstanding Balance as of the date of the request by the Redemption Conversion Price (as defined in the Note). Company shall further
require the Transfer Agent to hold the Ordinary Shares reserved pursuant to the Share Reserve exclusively for the benefit of Investor
and to issue such shares to Investor promptly upon Investor’s delivery of a Redemption Notice under the Note. Finally, Company
shall require the Transfer Agent to issue Ordinary Shares pursuant to the Note to Investor out of its authorized and unissued shares,
and not the Share Reserve, to the extent Ordinary Shares have been authorized, but not issued, and are not included in the Share Reserve.
The Transfer Agent shall only issue shares out of the Share Reserve to the extent there are no other authorized shares available for
issuance and then only with Investor’s written consent.

 

8.   OFAC;
Patriot Act.

 

8.1.   OFAC
Certification. Company certifies that (i) it is not acting on behalf of any person, group, entity, or nation named by any Executive
Order or the United States Treasury Department, through its Office of Foreign Assets Control (“OFAC”) or otherwise,
as a terrorist, “Specially Designated Nation”, “Blocked Person”, or other banned or blocked person, entity, nation,
or transaction pursuant to any law, order, rule or regulation that is enforced or administered by OFAC or another department of the United
States government, and (ii) Company is not engaged in this transaction on behalf of, or instigating or facilitating this transaction
on behalf of, any such person, group, entity or nation.

 

8.2.   Foreign
Corrupt Practices. Neither Company, nor any of its subsidiaries, nor any director, officer, agent, employee or other person acting
on behalf of Company or any subsidiary has, in the course of his actions for, or on behalf of, Company, used any corporate funds for
any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made any direct or indirect
unlawful payment to any foreign or domestic government official or employee from corporate funds; violated or is in violation of any
provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

    4

     

    

 

8.3.   Patriot
Act. Company shall not (i) be or become subject at any time to any law, regulation, or list of any government agency (including,
without limitation, the OFAC) that prohibits or limits Investor from making any advance or extension of credit to Company or from otherwise
conducting business with Company, or (ii) fail to provide documentary and other evidence of Company’s identity as may be requested
by Investor at any time to enable Investor to verify Company’s identity or to comply with any applicable law or regulation, including,
without limitation, Section 326 of the USA Patriot Act of 2001, 31 U.S.C. Section 5318. Company shall comply with all requirements of
law relating to money laundering, anti-terrorism, trade embargos and economic sanctions, now or hereafter in effect. Upon Investor’s
request from time to time, Company shall certify in writing to Investor that Company’s representations, warranties and obligations
under this Section 8.3 remain true and correct and have not been breached. Company shall immediately notify Investor in writing if any
of such representations, warranties or covenants are no longer true or have been breached or if Company has a reasonable basis to believe
that they may no longer be true or have been breached. In connection with such an event, Company shall comply with all requirements of
law and directives of governmental authorities and, at Investor’s request, provide to Investor copies of all notices, reports and
other communications exchanged with, or received from, governmental authorities relating to such an event. Company shall also reimburse
Investor any expense incurred by Investor in evaluating the effect of such an event on the loan secured hereby, in obtaining any necessary
license from governmental authorities as may be necessary for Investor to enforce its rights under the Transaction Documents, and in
complying with all requirements of law applicable to Investor as the result of the existence of such an event and for any penalties or
fines imposed upon Investor as a result thereof.

 

9.   Miscellaneous.
The provisions set forth in this Section 9 shall apply to this Agreement, as well as all other Transaction Documents as if these terms
were fully set forth therein; provided, however, that in the event there is a conflict between any provision set forth in this Section
9 and any provision in any other Transaction Document, the provision in such other Transaction Document shall govern.

 

9.1.   Arbitration
of Claims. The parties shall submit all Claims (as defined in Exhibit D) arising under this Agreement or any other Transaction
Document or any other agreement between the parties and their affiliates or any Claim relating to the relationship of the parties to
binding arbitration pursuant to the arbitration provisions set forth in Exhibit D attached hereto (the “Arbitration Provisions”).
For the avoidance of doubt, the parties agree that the injunction described in Section 9.3 below may be pursued in an arbitration that
is separate and apart from any other arbitration regarding all other Claims arising under the Transaction Documents. The parties hereby
acknowledge and agree that the Arbitration Provisions are unconditionally binding on the parties hereto and are severable from all other
provisions of this Agreement. By executing this Agreement, Company represents, warrants and covenants that Company has reviewed the Arbitration
Provisions carefully, consulted with legal counsel about such provisions (or waived its right to do so), understands that the Arbitration
Provisions are intended to allow for the expeditious and efficient resolution of any dispute hereunder, agrees to the terms and limitations
set forth in the Arbitration Provisions, and that Company will not take a position contrary to the foregoing representations. Company
acknowledges and agrees that Investor may rely upon the foregoing representations and covenants of Company regarding the Arbitration
Provisions.

 

9.2.   Governing
Law; Venue. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity,
interpretation and performance of this Agreement shall be governed by, the internal laws of the State of Utah, without giving effect
to any choice of law or conflict of law provision or rule (whether of the State of Utah or any other jurisdiction) that would cause the
application of the laws of any jurisdiction other than the State of Utah. Each party consents to and expressly agrees that the exclusive
venue for arbitration of any dispute arising out of or relating to any Transaction Document or the relationship of the parties or their
affiliates shall be in Salt Lake County, Utah. Without modifying the parties’ obligations to resolve disputes hereunder pursuant
to the Arbitration Provisions, for any litigation arising in connection with any of the Transaction Documents (and notwithstanding the
terms (specifically including any governing law and venue terms) of any transfer agent services agreement or other agreement between
the Transfer Agent and Company, such litigation specifically includes, without limitation any action between or involving Company and
the Transfer Agent under the TA Letter or otherwise related to Investor in any way (specifically including, without limitation, any action
where Company seeks to obtain an injunction, temporary restraining order, or otherwise prohibit the Transfer Agent from issuing Ordinary
Shares to Investor for any reason)), each party hereto hereby (i) consents to and expressly submits to the exclusive personal jurisdiction
of any state or federal court sitting in Salt Lake County, Utah, (ii) expressly submits to the exclusive venue of any such court for
the purposes hereof, (iii) agrees to not bring any such action (specifically including, without limitation, any action where Company
seeks to obtain an injunction, temporary restraining order, or otherwise prohibit the Transfer Agent from issuing Ordinary Shares to
Investor for any reason) outside of any state or federal court sitting in Salt Lake County, Utah, and (iv) waives any claim of improper
venue and any claim or objection that such courts are an inconvenient forum or any other claim, defense or objection to the bringing
of any such proceeding in such jurisdiction or to any claim that such venue of the suit, action or proceeding is improper. Finally, Company
covenants and agrees to name Investor as a party in interest in, and provide written notice to Investor in accordance with Section 9.10
below prior to bringing or filing, any action (including without limitation any filing or action against any person or entity that is
not a party to this Agreement, including without limitation the Transfer Agent) that is related in any way to the Transaction Documents
or any transaction contemplated herein or therein, including without limitation any action brought by Company to enjoin or prevent the
issuance of any Ordinary Shares to Investor by the Transfer Agent, and further agrees to timely name Investor as a party to any such
action. Company acknowledges that the governing law and venue provisions set forth in this Section 9.2 are material terms to induce Investor
to enter into the Transaction Documents and that but for Company’s agreements set forth in this Section 9.2 Investor would not
have entered into the Transaction Documents.

 

    5

     

    

 

9.3.   Specific
Performance. Company acknowledges and agrees that Investor may suffer irreparable harm in the event that Company fails to perform
any material provision of this Agreement or any of the other Transaction Documents in accordance with its specific terms. It is accordingly
agreed that Investor shall be entitled to one or more injunctions to prevent or cure breaches of the provisions of this Agreement or
such other Transaction Document and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any
other remedy to which the Investor may be entitled under the Transaction Documents, at law or in equity. Company specifically agrees
that: (a) following an Event of Default (as defined in the Note) under the Note, Investor shall have the right to seek and receive injunctive
relief from a court or an arbitrator prohibiting Company from issuing any of its common or preferred stock to any party unless the Note
is being paid in full simultaneously with such issuance; and (b) following a breach of Section 4(vi) above, Investor shall have the right
to seek and receive injunctive relief from a court or arbitrator invalidating such lock-up. Company specifically acknowledges that Investor’s
right to obtain specific performance constitutes bargained for leverage and that the loss of such leverage would result in irreparable
harm to Investor. For the avoidance of doubt, in the event Investor seeks to obtain an injunction from a court or an arbitrator against
Company or specific performance of any provision of any Transaction Document, such action shall not be a waiver of any right of Investor
under any Transaction Document, at law, or in equity, including without limitation its rights to arbitrate any Claim pursuant to the
terms of the Transaction Documents, nor shall Investor’s pursuit of an injunction prevent Investor, under the doctrines of claim
preclusion, issues preclusion, res judicata or other similar legal doctrines, from pursuing other Claims in the future in a separate
arbitration.

 

9.4.   Calculation
Disputes. Notwithstanding the Arbitration Provisions, in the case of a dispute as to any determination or arithmetic calculation
under the Transaction Documents, including without limitation, calculating the Outstanding Balance, Redemption Conversion Price, Conversion
Shares (as defined in the Note), or VWAP (as defined in the Note) (each, a “Calculation”), Company or Investor (as
the case may be) shall submit any disputed Calculation via email or facsimile with confirmation of receipt (i) within two (2) Trading
Days after receipt of the applicable notice giving rise to such dispute to Company or Investor (as the case may be) or (ii) if no notice
gave rise to such dispute, at any time after Investor learned of the circumstances giving rise to such dispute. If Investor and Company
are unable to agree upon such Calculation within two (2) Trading Days of such disputed Calculation being submitted to Company or Investor
(as the case may be), then Investor will promptly submit via email or facsimile the disputed Calculation to Unkar Systems Inc. (“Unkar
Systems”). Investor shall cause Unkar Systems to perform the Calculation and notify Company and Investor of the results no
later than ten (10) Trading Days from the time it receives such disputed Calculation. Unkar Systems’ determination of the disputed
Calculation shall be binding upon all parties absent demonstrable error. Unkar Systems’ fee for performing such Calculation shall
be paid by the incorrect party, or if both parties are incorrect, by the party whose Calculation is furthest from the correct Calculation
as determined by Unkar Systems. In the event Company is the losing party, no extension of the Delivery Date (as defined in the Note)
shall be granted and Company shall incur all effects for failing to deliver the applicable shares in a timely manner as set forth in
the Transaction Documents. Notwithstanding the foregoing, Investor may, in its sole discretion, designate an independent, reputable investment
bank or accounting firm other than Unkar Systems to resolve any such dispute and in such event, all references to “Unkar Systems”
herein will be replaced with references to such independent, reputable investment bank or accounting firm so designated by Investor.

 

9.5.
Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and
effective for all purposes.

 

    6

     

    

 

9.6.   Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this
Agreement.

 

9.7.   Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform to such statute
or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability
of any other provision hereof.

 

9.8.   Entire
Agreement. This Agreement, together with the other Transaction Documents, contains the entire understanding of the parties with respect
to the matters covered herein and therein and, except as specifically set forth herein or therein, neither Company nor Investor makes
any representation, warranty, covenant or undertaking with respect to such matters. For the avoidance of doubt, all prior term sheets
or other documents between Company and Investor, or any affiliate thereof, related to the transactions contemplated by the Transaction
Documents (collectively, “Prior Agreements”), that may have been entered into between Company and Investor, or any
affiliate thereof, are hereby null and void and deemed to be replaced in their entirety by the Transaction Documents. To the extent there
is a conflict between any term set forth in any Prior Agreement and the term(s) of the Transaction Documents, the Transaction Documents
shall govern.

 

9.9.   Amendments.
No provision of this Agreement may be waived or amended other than by an instrument in writing signed by both parties hereto.

 

9.10.   Notices.
Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be deemed effectively
given on the earliest of: (i) the date delivered, if delivered by personal delivery as against written receipt therefor or by email to
an executive officer named below or such officer’s successor, or by facsimile (with successful transmission confirmation which
is kept by sending party), (ii) the earlier of the date delivered or the fifth (5th) Trading Day after deposit, postage prepaid,
with an international courier, or (iii) the earlier of the date delivered or the third Trading Day after mailing by express courier,
with delivery costs and fees prepaid, in each case, addressed to each of the other parties thereunto entitled at the following addresses
(or at such other addresses as such party may designate by five (5) calendar days’ advance written notice similarly given to each
of the other parties hereto):

 

If
to Company:

 

China
SXT Pharmaceuticals, Inc.

Attn:
Feng Zhou

178
Taidong Road North, Taizhou

Jiangsu,
China

Email:
fzhou@sxtchina.com

 

With
a copy to (which copy shall not constitute notice):

 

Hunter
Taubman Fischer & Li LLC

Attn:
Joan Wu

48
Wall Street, Suite 1100

New
York, NY 10005

Email:
jwu@htflawyers.com

 

If
to Investor:

 

Streeterville
Capital, LLC

Attn:
John Fife and Chris Stalcup

303
East Wacker Drive, Suite 1040

Chicago,
Illinois 60601

Email:
jfife@chicagoventure.com and cstalcup@chicagoventure.com

 

With
a copy to (which copy shall not constitute notice):

 

Hansen
Black Anderson Ashcraft PLLC

Attn:
Jonathan Hansen

3051
West Maple Loop Drive, Suite 325

Lehi,
Utah 84043

Email:
jhansen@hbaa.law

 

    7

     

    

 

9.11.   Successors
and Assigns. This Agreement or any of the severable rights and obligations inuring to the benefit of or to be performed by Investor
hereunder may be assigned by Investor to a third party, including its affiliates, in whole or in part, without the need to obtain Company’s
consent thereto. Company may not assign its rights or obligations under this Agreement or delegate its duties hereunder, whether directly
or indirectly, without the prior written consent of Investor, and any such attempted assignment or delegation shall be null and void.

 

9.12.   Survival.
The representations and warranties of Company and the agreements and covenants set forth in this Agreement shall survive the Closing
hereunder notwithstanding any due diligence investigation conducted by or on behalf of Investor. Company agrees to indemnify and hold
harmless Investor and all its officers, directors, employees, attorneys, and agents for loss or damage arising as a result of or related
to any breach or alleged breach by Company of any of its representations, warranties and covenants set forth in this Agreement or any
of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

9.13.   Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

9.14.   Investor’s
Rights and Remedies Cumulative. All rights, remedies, and powers conferred in this Agreement and the Transaction Documents are cumulative
and not exclusive of any other rights or remedies, and shall be in addition to every other right, power, and remedy that Investor may
have, whether specifically granted in this Agreement or any other Transaction Document, or existing at law, in equity, or by statute,
and any and all such rights and remedies may be exercised from time to time and as often and in such order as Investor may deem expedient.

 

9.15.   Attorneys’
Fees and Cost of Collection. In the event any suit, action or arbitration is filed by either party against the other to interpret
or enforce any of the Transaction Documents, the unsuccessful party to such action agrees to pay to the prevailing party all costs and
expenses, including attorneys’ fees incurred therein, including the same with respect to an appeal. The “prevailing
party” shall be the party in whose favor a judgment is entered, regardless of whether judgment is entered on all claims asserted
by such party and regardless of the amount of the judgment; or where, due to the assertion of counterclaims, judgments are entered in
favor of and against both parties, then the judge or arbitrator shall determine the “prevailing party” by taking into account
the relative dollar amounts of the judgments or, if the judgments involve nonmonetary relief, the relative importance and value of such
relief. Nothing herein shall restrict or impair an arbitrator’s or a court’s power to award fees and expenses for frivolous
or bad faith pleading. If (i) the Note is placed in the hands of an attorney for collection or enforcement prior to commencing arbitration
or legal proceedings, or is collected or enforced through any arbitration or legal proceeding, or Investor otherwise takes action to
collect amounts due under the Note or to enforce the provisions of the Note, or (ii) there occurs any bankruptcy, reorganization,
receivership of Company or other proceedings affecting Company’s creditors’ rights and involving a claim under the Note;
then Company shall pay the costs incurred by Investor for such collection, enforcement or action or in connection with such bankruptcy,
reorganization, receivership or other proceeding, including, without limitation, attorneys’ fees, expenses, deposition costs, and
disbursements.

 

9.16.   Waiver.
No waiver of any provision of this Agreement shall be effective unless it is in the form of a writing signed by the party granting the
waiver. No waiver of any provision or consent to any prohibited action shall constitute a waiver of any other provision or consent to
any other prohibited action, whether or not similar. No waiver or consent shall constitute a continuing waiver or consent or commit a
party to provide a waiver or consent in the future except to the extent specifically set forth in writing.

 

    8

     

    

 

9.17.   Waiver
of Jury Trial. EACH PARTY TO THIS AGREEMENT IRREVOCABLY WAIVES ANY AND ALL RIGHTS SUCH PARTY MAY HAVE TO DEMAND THAT ANY ACTION,
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT, OR THE RELATIONSHIPS
OF THE PARTIES HERETO BE TRIED BY JURY. THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING UNDER COMMON LAW
OR ANY APPLICABLE STATUTE, LAW, RULE OR REGULATION. FURTHER, EACH PARTY HERETO ACKNOWLEDGES THAT SUCH PARTY IS KNOWINGLY AND VOLUNTARILY
WAIVING SUCH PARTY’S RIGHT TO DEMAND TRIAL BY JURY.

 

9.18.   Time
is of the Essence. Time is expressly made of the essence with respect to each and every provision of this Agreement and the other
Transaction Documents.

 

9.19.   Voluntary
Agreement. Company has carefully read this Agreement and each of the other Transaction Documents and has asked any questions needed
for Company to understand the terms, consequences and binding effect of this Agreement and each of the other Transaction Documents and
fully understand them. Company has had the opportunity to seek the advice of an attorney of Company’s choosing, or has waived the
right to do so, and is executing this Agreement and each of the other Transaction Documents voluntarily and without any duress or undue
influence by Investor or anyone else.

 

9.20.   Document
Imaging. Investor shall be entitled, in its sole discretion, to image or make copies of all or any selection of the agreements, instruments,
documents, and items and records governing, arising from or relating to any of Company’s loans, including, without limitation,
this Agreement and the other Transaction Documents, and Investor may destroy or archive the paper originals. The parties hereto
(i) waive any right to insist or require that Investor produce paper originals, (ii) agree that such images shall be accorded the same
force and effect as the paper originals, (iii) agree that Investor is entitled to use such images in lieu of destroyed or archived originals
for any purpose, including as admissible evidence in any demand, presentment or other proceedings, and (iv) further agree that any executed
facsimile (faxed), scanned, emailed, or other imaged copy of this Agreement or any other Transaction Document shall be deemed to be of
the same force and effect as the original manually executed document.

 

[Remainder
of page intentionally left blank; signature page follows]

 

    9

     

    

 

IN
WITNESS WHEREOF, the undersigned Investor and Company have caused this Agreement to be duly executed as of the date first above written.

 

	 	INVESTOR:
	 	 
	 	Streeterville
    Capital, LLC
	 	 	 
	 	By:	 
	 	 	John M. Fife, President

 

	 	COMPANY:
	 	 
	 	China
    SXT Pharmaceuticals, Inc.
	 	 	 
	 	By:	                           
	 	 	Feng Zhou, CEO

 

[Signature
Page to Securities Purchase Agreement]

 

     

     

    

 

ATTACHED
EXHIBITS:

 

Exhibit
A Note

Exhibit
B Irrevocable Transfer Agent Instructions

Exhibit
C Officer’s Certificate

Exhibit
D Arbitration Provisions

 

     

     

    

 

Exhibit
D

 

ARBITRATION
PROVISIONS

 

1.   Dispute
Resolution. For purposes of this Exhibit D, the term “Claims” means any disputes, claims, demands, causes
of action, requests for injunctive relief, requests for specific performance, questions regarding severability of any provisions of the
Transaction Documents, liabilities, damages, losses, or controversies whatsoever arising from, related to, or connected with the transactions
contemplated in the Transaction Documents and any communications between the parties related thereto, including without limitation any
claims of mutual mistake, mistake, fraud, misrepresentation, failure of formation, failure of consideration, promissory estoppel, unconscionability,
failure of condition precedent, rescission, and any statutory claims, tort claims, contract claims, or claims to void, invalidate or
terminate the Agreement (or these Arbitration Provisions (defined below)) or any of the other Transaction Documents. The term “Claims”
specifically excludes a dispute over Calculations. The parties to this Agreement (the “parties”) hereby agree that
the Claims may be arbitrated in one or more Arbitrations pursuant to these Arbitration Provisions (one for an injunction or injunctions
and a separate one for all other Claims). The parties hereby agree that the arbitration provisions set forth in this Exhibit D
(“Arbitration Provisions”) are binding on each of them. As a result, any attempt to rescind the Agreement (or these
Arbitration Provisions) or any other Transaction Document) or declare the Agreement (or these Arbitration Provisions) or any other Transaction
Document invalid or unenforceable pursuant to Section 29 of the 1934 Act or for any other reason is subject to these Arbitration Provisions.
These Arbitration Provisions shall also survive any termination or expiration of the Agreement. Any capitalized term not defined in these
Arbitration Provisions shall have the meaning set forth in the Agreement.

 

2.   Arbitration.
Except as otherwise provided herein, all Claims must be submitted to arbitration (“Arbitration”) to be conducted exclusively
in Salt Lake County, Utah and pursuant to the terms set forth in these Arbitration Provisions. Subject to the arbitration appeal right
provided for in Paragraph 5 below (the “Appeal Right”), the parties agree that the award of the arbitrator rendered
pursuant to Paragraph 4 below (the “Arbitration Award”) shall be (a) final and binding upon the parties, (b) the sole
and exclusive remedy between them regarding any Claims, counterclaims, issues, or accountings presented or pleaded to the arbitrator,
and (c) promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Subject to
the Appeal Right, any costs or fees, including without limitation attorneys’ fees, incurred in connection with or incident to enforcing
the Arbitration Award shall, to the maximum extent permitted by law, be charged against the party resisting such enforcement. The Arbitration
Award shall include default interest (as defined or otherwise provided for in the Note, “Default Interest”) (with
respect to monetary awards) at the rate specified in the Note for Default Interest both before and after the Arbitration Award. Judgment
upon the Arbitration Award will be entered and enforced by any state or federal court sitting in Salt Lake County, Utah.

 

3.   The
Arbitration Act. The parties hereby incorporate herein the provisions and procedures set forth in the Utah Uniform Arbitration Act,
U.C.A. § 78B-11-101 et seq. (as amended or superseded from time to time, the “Arbitration Act”). Notwithstanding
the foregoing, pursuant to, and to the maximum extent permitted by, Section 105 of the Arbitration Act, in the event of conflict or variation
between the terms of these Arbitration Provisions and the provisions of the Arbitration Act, the terms of these Arbitration Provisions
shall control and the parties hereby waive or otherwise agree to vary the effect of all requirements of the Arbitration Act that may
conflict with or vary from these Arbitration Provisions.

 

4.   Arbitration
Proceedings. Arbitration between the parties will be subject to the following:

 

4.1   Initiation
of Arbitration. Pursuant to Section 110 of the Arbitration Act, the parties agree that a party may initiate Arbitration by giving
written notice to the other party (“Arbitration Notice”) in the same manner that notice is permitted under Section
9.10 of the Agreement; provided, however, that the Arbitration Notice may not be given by email or fax. Arbitration will be deemed
initiated as of the date that the Arbitration Notice is deemed delivered to such other party under Section 9.10 of the Agreement (the
“Service Date”). After the Service Date, information may be delivered, and notices may be given, by email or fax pursuant
to Section 9.10 of the Agreement or any other method permitted thereunder. The Arbitration Notice must describe the nature of the controversy,
the remedies sought, and the election to commence Arbitration proceedings. All Claims in the Arbitration Notice must be pleaded consistent
with the Utah Rules of Civil Procedure.

 

4.2   Selection
and Payment of Arbitrator.

 

 (a)
Within ten (10) calendar days after the Service Date, Investor shall select and submit to Company the names of three (3) arbitrators
that are designated as “neutrals” or qualified arbitrators by Utah ADR Services (http://www.utahadrservices.com) (such three
(3) designated persons hereunder are referred to herein as the “Proposed Arbitrators”). For the avoidance of doubt,
each Proposed Arbitrator must be qualified as a “neutral” with Utah ADR Services. Within five (5) calendar days after Investor
has submitted to Company the names of the Proposed Arbitrators, Company must select, by written notice to Investor, one (1) of the Proposed
Arbitrators to act as the arbitrator for the parties under these Arbitration Provisions. If Company fails to select one of the Proposed
Arbitrators in writing within such 5-day period, then Investor may select the arbitrator from the Proposed Arbitrators by providing written
notice of such selection to Company.

 

     

     

    

 (b)
If Investor fails to submit to Company the Proposed Arbitrators within ten (10) calendar days after the Service Date pursuant to subparagraph
(a) above, then Company may at any time prior to Investor so designating the Proposed Arbitrators, identify the names of three (3) arbitrators
that are designated as “neutrals” or qualified arbitrators by Utah ADR Service by written notice to Investor. Investor may
then, within five (5) calendar days after Company has submitted notice of its Proposed Arbitrators to Investor, select, by written notice
to Company, one (1) of the Proposed Arbitrators to act as the arbitrator for the parties under these Arbitration Provisions. If Investor
fails to select in writing and within such 5-day period one (1) of the three (3) Proposed Arbitrators selected by Company, then Company
may select the arbitrator from its three (3) previously selected Proposed Arbitrators by providing written notice of such selection to
Investor.

 

 (c)
If a Proposed Arbitrator chosen to serve as arbitrator declines or is otherwise unable to serve as arbitrator, then the party that selected
such Proposed Arbitrator may select one (1) of the other three (3) Proposed Arbitrators within three (3) calendar days of the date the
chosen Proposed Arbitrator declines or notifies the parties he or she is unable to serve as arbitrator. If all three (3) Proposed Arbitrators
decline or are otherwise unable to serve as arbitrator, then the arbitrator selection process shall begin again in accordance with this
Paragraph 4.2.

 

 (d)
The date that the Proposed Arbitrator selected pursuant to this Paragraph 4.2 agrees in writing (including via email) delivered to both
parties to serve as the arbitrator hereunder is referred to herein as the “Arbitration Commencement Date”. If an arbitrator
resigns or is unable to act during the Arbitration, a replacement arbitrator shall be chosen in accordance with this Paragraph 4.2 to
continue the Arbitration. If Utah ADR Services ceases to exist or to provide a list of neutrals and there is no successor thereto, then
the arbitrator shall be selected under the then prevailing rules of the American Arbitration Association.

 

 (e)
Subject to Paragraph 4.10 below, the cost of the arbitrator must be paid equally by both parties. Subject to Paragraph 4.10 below, if
one party refuses or fails to pay its portion of the arbitrator fee, then the other party can advance such unpaid amount (subject to
the accrual of Default Interest thereupon), with such amount being added to or subtracted from, as applicable, the Arbitration Award.

 

4.3   Applicability
of Certain Utah Rules. The parties agree that the Arbitration shall be conducted generally in accordance with the Utah Rules of Civil
Procedure and the Utah Rules of Evidence. More specifically, the Utah Rules of Civil Procedure shall apply, without limitation, to the
filing of any pleadings, motions or memoranda, the conducting of discovery, and the taking of any depositions. The Utah Rules of Evidence
shall apply to any hearings, whether telephonic or in person, held by the arbitrator. Notwithstanding the foregoing, it is the parties’
intent that the incorporation of such rules will in no event supersede these Arbitration Provisions. In the event of any conflict between
the Utah Rules of Civil Procedure or the Utah Rules of Evidence and these Arbitration Provisions, these Arbitration Provisions shall
control.

 

4.4   Answer
and Default. An answer and any counterclaims to the Arbitration Notice shall be required to be delivered to the party initiating
the Arbitration within twenty (20) calendar days after the Arbitration Commencement Date. If an answer is not delivered by the required
deadline, the arbitrator must provide written notice to the defaulting party stating that the arbitrator will enter a default award against
such party if such party does not file an answer within five (5) calendar days of receipt of such notice. If an answer is not filed within
the five (5) day extension period, the arbitrator must render a default award, consistent with the relief requested in the Arbitration
Notice, against a party that fails to submit an answer within such time period.

 

4.5   Related
Litigation. The party that delivers the Arbitration Notice to the other party shall have the option to also commence concurrent legal
proceedings with any state or federal court sitting in Salt Lake County, Utah (“Litigation Proceedings”), subject
to the following: (a) the complaint in the Litigation Proceedings is to be substantially similar to the claims set forth in the Arbitration
Notice, provided that an additional cause of action to compel arbitration will also be included therein, (b) so long as the other party
files an answer to the complaint in the Litigation Proceedings and an answer to the Arbitration Notice, the Litigation Proceedings will
be stayed pending an Arbitration Award (or Appeal Panel Award (defined below), as applicable) hereunder, (c) if the other party fails
to file an answer in the Litigation Proceedings or an answer in the Arbitration proceedings, then the party initiating Arbitration shall
be entitled to a default judgment consistent with the relief requested, to be entered in the Litigation Proceedings, and (d) any legal
or procedural issue arising under the Arbitration Act that requires a decision of a court of competent jurisdiction may be determined
in the Litigation Proceedings. Any award of the arbitrator (or of the Appeal Panel (defined below)) may be entered in such Litigation
Proceedings pursuant to the Arbitration Act.

 

4.6   Discovery.
Pursuant to Section 118(8) of the Arbitration Act, the parties agree that discovery shall be conducted as follows:

 

 (a)
Written discovery will only be allowed if the likely benefits of the proposed written discovery outweigh the burden or expense thereof,
and the written discovery sought is likely to reveal information that will satisfy a specific element of a claim or defense already pleaded
in the Arbitration. The party seeking written discovery shall always have the burden of showing that all of the standards and limitations
set forth in these Arbitration Provisions are satisfied. The scope of discovery in the Arbitration proceedings shall also be limited
as follows:

 

(i)   To
facts directly connected with the transactions contemplated by the Agreement.

 

(ii)   To
facts and information that cannot be obtained from another source or in another manner that is more convenient, less burdensome or less
expensive than in the manner requested.

 

     

     

    

 

 (b)
No party shall be allowed (i) more than fifteen (15) interrogatories (including discrete subparts), (ii) more than fifteen (15) requests
for admission (including discrete subparts), (iii) more than ten (10) document requests (including discrete subparts), or (iv) more than
three (3) depositions (excluding expert depositions) for a maximum of seven (7) hours per deposition. The costs associated with depositions
will be borne by the party taking the deposition. The party defending the deposition will submit a notice to the party taking the deposition
of the estimated attorneys’ fees that such party expects to incur in connection with defending the deposition. If the party defending
the deposition fails to submit an estimate of attorneys’ fees within five (5) calendar days of its receipt of a deposition notice,
then such party shall be deemed to have waived its right to the estimated attorneys’ fees. The party taking the deposition must
pay the party defending the deposition the estimated attorneys’ fees prior to taking the deposition, unless such obligation is
deemed to be waived as set forth in the immediately preceding sentence. If the party taking the deposition believes that the estimated
attorneys’ fees are unreasonable, such party may submit the issue to the arbitrator for a decision. All depositions will be taken
in Utah.

 

 (c)
All discovery requests (including document production requests included in deposition notices) must be submitted in writing to the arbitrator
and the other party. The party submitting the written discovery requests must include with such discovery requests a detailed explanation
of how the proposed discovery requests satisfy the requirements of these Arbitration Provisions and the Utah Rules of Civil Procedure.
The receiving party will then be allowed, within five (5) calendar days of receiving the proposed discovery requests, to submit to the
arbitrator an estimate of the attorneys’ fees and costs associated with responding to such written discovery requests and a written
challenge to each applicable discovery request. After receipt of an estimate of attorneys’ fees and costs and/or challenge(s) to
one or more discovery requests, consistent with subparagraph (c) above, the arbitrator will within three (3) calendar days make a finding
as to the likely attorneys’ fees and costs associated with responding to the discovery requests and issue an order that (i) requires
the requesting party to prepay the attorneys’ fees and costs associated with responding to the discovery requests, and (ii) requires
the responding party to respond to the discovery requests as limited by the arbitrator within twenty-five (25) calendar days of the arbitrator’s
finding with respect to such discovery requests. If a party entitled to submit an estimate of attorneys’ fees and costs and/or
a challenge to discovery requests fails to do so within such 5-day period, the arbitrator will make a finding that (A) there are no attorneys’
fees or costs associated with responding to such discovery requests, and (B) the responding party must respond to such discovery requests
(as may be limited by the arbitrator) within twenty-five (25) calendar days of the arbitrator’s finding with respect to such discovery
requests. Any party submitting any written discovery requests, including without limitation interrogatories, requests for production
subpoenas to a party or a third party, or requests for admissions, must prepay the estimated attorneys’ fees and costs, before
the responding party has any obligation to produce or respond to the same, unless such obligation is deemed waived as set forth above.

 

 (d)
In order to allow a written discovery request, the arbitrator must find that the discovery request satisfies the standards set forth
in these Arbitration Provisions and the Utah Rules of Civil Procedure. The arbitrator must strictly enforce these standards. If a discovery
request does not satisfy any of the standards set forth in these Arbitration Provisions or the Utah Rules of Civil Procedure, the arbitrator
may modify such discovery request to satisfy the applicable standards, or strike such discovery request in whole or in part.

 

 (e)
Each party may submit expert reports (and rebuttals thereto), provided that such reports must be submitted within sixty (60) days of
the Arbitration Commencement Date. Each party will be allowed a maximum of two (2) experts. Expert reports must contain the following:
(i) a complete statement of all opinions the expert will offer at trial and the basis and reasons for them; (ii) the expert’s name
and qualifications, including a list of all the expert’s publications within the preceding ten (10) years, and a list of any other
cases in which the expert has testified at trial or in a deposition or prepared a report within the preceding ten (10) years; and (iii)
the compensation to be paid for the expert’s report and testimony. The parties are entitled to depose any other party’s expert
witness one (1) time for no more than four (4) hours. An expert may not testify in a party’s case-in-chief concerning any matter
not fairly disclosed in the expert report.

 

     

     

    

 

4.6   Dispositive
Motions. Each party shall have the right to submit dispositive motions pursuant Rule 12 or Rule 56 of the Utah Rules of Civil Procedure
(a “Dispositive Motion”). The party submitting the Dispositive Motion may, but is not required to, deliver to the
arbitrator and to the other party a memorandum in support (the “Memorandum in Support”) of the Dispositive Motion.
Within seven (7) calendar days of delivery of the Memorandum in Support, the other party shall deliver to the arbitrator and to the other
party a memorandum in opposition to the Memorandum in Support (the “Memorandum in Opposition”). Within seven (7) calendar
days of delivery of the Memorandum in Opposition, as applicable, the party that submitted the Memorandum in Support shall deliver to
the arbitrator and to the other party a reply memorandum to the Memorandum in Opposition (“Reply Memorandum”). If
the applicable party shall fail to deliver the Memorandum in Opposition as required above, or if the other party fails to deliver the
Reply Memorandum as required above, then the applicable party shall lose its right to so deliver the same, and the Dispositive Motion
shall proceed regardless.

 

4.7   Confidentiality.
All information disclosed by either party (or such party’s agents) during the Arbitration process (including without limitation
information disclosed during the discovery process or any Appeal (defined below)) shall be considered confidential in nature. Each party
agrees not to disclose any confidential information received from the other party (or its agents) during the Arbitration process (including
without limitation during the discovery process or any Appeal) unless (a) prior to or after the time of disclosure such information becomes
public knowledge or part of the public domain, not as a result of any inaction or action of the receiving party or its agents, (b) such
information is required by a court order, subpoena or similar legal duress to be disclosed if such receiving party has notified the other
party thereof in writing and given it a reasonable opportunity to obtain a protective order from a court of competent jurisdiction prior
to disclosure, or (c) such information is disclosed to the receiving party’s agents, representatives and legal counsel on a need
to know basis who each agree in writing not to disclose such information to any third party. Pursuant to Section 118(5) of the Arbitration
Act, the arbitrator is hereby authorized and directed to issue a protective order to prevent the disclosure of privileged information
and confidential information upon the written request of either party.

 

4.8   Authorization;
Timing; Scheduling Order. Subject to all other portions of these Arbitration Provisions, the parties hereby authorize and direct
the arbitrator to take such actions and make such rulings as may be necessary to carry out the parties’ intent for the Arbitration
proceedings to be efficient and expeditious. Pursuant to Section 120 of the Arbitration Act, the parties hereby agree that an Arbitration
Award must be made within one hundred twenty (120) calendar days after the Arbitration Commencement Date. The arbitrator is hereby authorized
and directed to hold a scheduling conference within ten (10) calendar days after the Arbitration Commencement Date in order to establish
a scheduling order with various binding deadlines for discovery, expert testimony, and the submission of documents by the parties to
enable the arbitrator to render a decision prior to the end of such 120-day period.

 

4.9   Relief.
The arbitrator shall have the right to award or include in the Arbitration Award (or in a preliminary ruling) any relief which the arbitrator
deems proper under the circumstances, including, without limitation, specific performance and injunctive relief, provided that the arbitrator
may not award exemplary or punitive damages.

 

4.10   Fees
and Costs. As part of the Arbitration Award, the arbitrator is hereby directed to require the losing party (the party being awarded
the least amount of money by the arbitrator, which, for the avoidance of doubt, shall be determined without regard to any statutory fines,
penalties, fees, or other charges awarded to any party) to (a) pay the full amount of any unpaid costs and fees of the Arbitration, and
(b) reimburse the prevailing party for all reasonable attorneys’ fees, arbitrator costs and fees, deposition costs, other discovery
costs, and other expenses, costs or fees paid or otherwise incurred by the prevailing party in connection with the Arbitration.

 

     

     

    

 

5.   Arbitration
Appeal.

 

5.1   Initiation
of Appeal. Following the entry of the Arbitration Award, either party (the “Appellant”) shall have a period of
thirty (30) calendar days in which to notify the other party (the “Appellee”), in writing, that the Appellant elects
to appeal (the “Appeal”) the Arbitration Award (such notice, an “Appeal Notice”) to a panel of
arbitrators as provided in Paragraph 5.2 below. The date the Appellant delivers an Appeal Notice to the Appellee is referred to herein
as the “Appeal Date”. The Appeal Notice must be delivered to the Appellee in accordance with the provisions of Paragraph
4.1 above with respect to delivery of an Arbitration Notice. In addition, together with delivery of the Appeal Notice to the Appellee,
the Appellant must also pay for (and provide proof of such payment to the Appellee together with delivery of the Appeal Notice) a bond
in the amount of 110% of the sum the Appellant owes to the Appellee as a result of the Arbitration Award the Appellant is appealing.
In the event an Appellant delivers an Appeal Notice to the Appellee (together with proof of payment of the applicable bond) in compliance
with the provisions of this Paragraph 5.1, the Appeal will occur as a matter of right and, except as specifically set forth herein, will
not be further conditioned. In the event a party does not deliver an Appeal Notice (along with proof of payment of the applicable bond)
to the other party within the deadline prescribed in this Paragraph 5.1, such party shall lose its right to appeal the Arbitration Award.
If no party delivers an Appeal Notice (along with proof of payment of the applicable bond) to the other party within the deadline described
in this Paragraph 5.1, the Arbitration Award shall be final. The parties acknowledge and agree that any Appeal shall be deemed part of
the parties’ agreement to arbitrate for purposes of these Arbitration Provisions and the Arbitration Act.

 

5.2   Selection
and Payment of Appeal Panel. In the event an Appellant delivers an Appeal Notice to the Appellee (together with proof of payment
of the applicable bond) in compliance with the provisions of Paragraph 5.1 above, the Appeal will be heard by a three (3) person arbitration
panel (the “Appeal Panel”).

 

 (a)
 Within ten (10) calendar days after the Appeal Date, the Appellee shall select and submit to the Appellant the names of five (5)
arbitrators that are designated as “neutrals” or qualified arbitrators by Utah ADR Services (http://www.utahadrservices.com)
(such five (5) designated persons hereunder are referred to herein as the “Proposed Appeal Arbitrators”). For the
avoidance of doubt, each Proposed Appeal Arbitrator must be qualified as a “neutral” with Utah ADR Services, and shall not
be the arbitrator who rendered the Arbitration Award being appealed (the “Original Arbitrator”). Within five (5) calendar
days after the Appellee has submitted to the Appellant the names of the Proposed Appeal Arbitrators, the Appellant must select, by written
notice to the Appellee, three (3) of the Proposed Appeal Arbitrators to act as the members of the Appeal Panel. If the Appellant fails
to select three (3) of the Proposed Appeal Arbitrators in writing within such 5-day period, then the Appellee may select such three (3)
arbitrators from the Proposed Appeal Arbitrators by providing written notice of such selection to the Appellant.

 

 (b)
 If the Appellee fails to submit to the Appellant the names of the Proposed Appeal Arbitrators within ten (10) calendar days after
the Appeal Date pursuant to subparagraph (a) above, then the Appellant may at any time prior to the Appellee so designating the Proposed
Appeal Arbitrators, identify the names of five (5) arbitrators that are designated as “neutrals” or qualified arbitrators
by Utah ADR Service (none of whom may be the Original Arbitrator) by written notice to the Appellee. The Appellee may then, within five
(5) calendar days after the Appellant has submitted notice of its selected arbitrators to the Appellee, select, by written notice to
the Appellant, three (3) of such selected arbitrators to serve on the Appeal Panel. If the Appellee fails to select in writing within
such 5-day period three (3) of the arbitrators selected by the Appellant to serve as the members of the Appeal Panel, then the Appellant
may select the three (3) members of the Appeal Panel from the Appellant’s list of five (5) arbitrators by providing written notice
of such selection to the Appellee.

 

 (c)
 If a selected Proposed Appeal Arbitrator declines or is otherwise unable to serve, then the party that selected such Proposed Appeal
Arbitrator may select one (1) of the other five (5) designated Proposed Appeal Arbitrators within three (3) calendar days of the date
a chosen Proposed Appeal Arbitrator declines or notifies the parties he or she is unable to serve as an arbitrator. If at least three
(3) of the five (5) designated Proposed Appeal Arbitrators decline or are otherwise unable to serve, then the Proposed Appeal Arbitrator
selection process shall begin again in accordance with this Paragraph 5.2; provided, however, that any Proposed Appeal Arbitrators
who have already agreed to serve shall remain on the Appeal Panel.

 

 (d) The
date that all three (3) Proposed Appeal Arbitrators selected pursuant to this Paragraph 5.2 agree in writing (including via email) delivered
to both the Appellant and the Appellee to serve as members of the Appeal Panel hereunder is referred to herein as the “Appeal
Commencement Date”. No later than five (5) calendar days after the Appeal Commencement Date, the Appellee shall designate in
writing (including via email) to the Appellant and the Appeal Panel the name of one (1) of the three (3) members of the Appeal Panel
to serve as the lead arbitrator in the Appeal proceedings. Each member of the Appeal Panel shall be deemed an arbitrator for purposes
of these Arbitration Provisions and the Arbitration Act, provided that, in conducting the Appeal, the Appeal Panel may only act or make
determinations upon the approval or vote of no less than the majority vote of its members, as announced or communicated by the lead arbitrator
on the Appeal Panel. If an arbitrator on the Appeal Panel ceases or is unable to act during the
Appeal proceedings, a replacement arbitrator shall be chosen in accordance with Paragraph 5.2 above to continue the Appeal as a member
of the Appeal Panel. If Utah ADR Services ceases to exist or to provide a list of neutrals, then the arbitrators for the Appeal
Panel shall be selected under the then prevailing rules of the American Arbitration Association.

 

(d)
 Subject to Paragraph 5.7 below, the cost of the Appeal Panel must be paid entirely by the Appellant.

 

     

     

    

 

5.3   Appeal
Procedure. The Appeal will be deemed an appeal of the entire Arbitration Award. In conducting the Appeal, the Appeal Panel shall
conduct a de novo review of all Claims described or otherwise set forth in the Arbitration Notice. Subject to the foregoing and all other
provisions of this Paragraph 5, the Appeal Panel shall conduct the Appeal in a manner the Appeal Panel considers appropriate for a fair
and expeditious disposition of the Appeal, may hold one or more hearings and permit oral argument, and may review all previous evidence
and discovery, together with all briefs, pleadings and other documents filed with the Original Arbitrator (as well as any documents filed
with the Appeal Panel pursuant to Paragraph 5.4(a) below). Notwithstanding the foregoing, in connection with the Appeal, the Appeal Panel
shall not permit the parties to conduct any additional discovery or raise any new Claims to be arbitrated, shall not permit new witnesses
or affidavits, and shall not base any of its findings or determinations on the Original Arbitrator’s findings or the Arbitration
Award.

 

5.4   Timing.

 

(a)   Within
seven (7) calendar days of the Appeal Commencement Date, the Appellant (i) shall deliver or cause to be delivered to the Appeal Panel
copies of the Appeal Notice, all discovery conducted in connection with the Arbitration, and all briefs, pleadings and other documents
filed with the Original Arbitrator (which material Appellee shall have the right to review and supplement if necessary), and (ii) may,
but is not required to, deliver to the Appeal Panel and to the Appellee a Memorandum in Support of the Appellant’s arguments concerning
or position with respect to all Claims, counterclaims, issues, or accountings presented or pleaded in the Arbitration. Within seven (7)
calendar days of the Appellant’s delivery of the Memorandum in Support, as applicable, the Appellee shall deliver to the Appeal
Panel and to the Appellant a Memorandum in Opposition to the Memorandum in Support. Within seven (7) calendar days of the Appellee’s
delivery of the Memorandum in Opposition, as applicable, the Appellant shall deliver to the Appeal Panel and to the Appellee a Reply
Memorandum to the Memorandum in Opposition. If the Appellant shall fail to substantially comply with the requirements of clause (i) of
this subparagraph (a), the Appellant shall lose its right to appeal the Arbitration Award, and the Arbitration Award shall be final.
If the Appellee shall fail to deliver the Memorandum in Opposition as required above, or if the Appellant shall fail to deliver the Reply
Memorandum as required above, then the Appellee or the Appellant, as the case may be, shall lose its right to so deliver the same, and
the Appeal shall proceed regardless.

 

(b)
   Subject to subparagraph (a) above, the parties hereby agree that the Appeal must be heard by
the Appeal Panel within thirty (30) calendar days of the Appeal Commencement Date, and that the Appeal Panel must render its decision
within thirty (30) calendar days after the Appeal is heard (and in no event later than sixty (60) calendar days after the Appeal Commencement
Date).

 

5.5   Appeal
Panel Award. The Appeal Panel shall issue its decision (the “Appeal Panel Award”) through the lead arbitrator
on the Appeal Panel. Notwithstanding any other provision contained herein, the Appeal Panel Award shall (a) supersede in its entirety
and make of no further force or effect the Arbitration Award (provided that any protective orders issued by the Original Arbitrator shall
remain in full force and effect), (b) be final and binding upon the parties, with no further rights of appeal, (c) be the sole and exclusive
remedy between the parties regarding any Claims, counterclaims, issues, or accountings presented or pleaded in the Arbitration, and (d)
be promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Any costs or fees,
including without limitation attorneys’ fees, incurred in connection with or incident to enforcing the Appeal Panel Award shall,
to the maximum extent permitted by law, be charged against the party resisting such enforcement. The Appeal Panel Award shall include
Default Interest (with respect to monetary awards) at the rate specified in the Note for Default Interest both before and after the Arbitration
Award. Judgment upon the Appeal Panel Award will be entered and enforced by a state or federal court sitting in Salt Lake County, Utah.

 

5.6   Relief.
The Appeal Panel shall have the right to award or include in the Appeal Panel Award any relief which the Appeal Panel deems proper
under the circumstances, including, without limitation, specific performance and injunctive relief, provided that the Appeal Panel may
not award exemplary or punitive damages.

 

5.7   Fees
and Costs. As part of the Appeal Panel Award, the Appeal Panel is hereby directed to require the losing party (the party being awarded
the least amount of money by the arbitrator, which, for the avoidance of doubt, shall be determined without regard to any statutory fines,
penalties, fees, or other charges awarded to any party) to (a) pay the full amount of any unpaid costs and fees of the Arbitration and
the Appeal Panel, and (b) reimburse the prevailing party (the party being awarded the most amount of money by the Appeal Panel, which,
for the avoidance of doubt, shall be determined without regard to any statutory fines, penalties, fees, or other charges awarded to any
part) the reasonable attorneys’ fees, arbitrator and Appeal Panel costs and fees, deposition costs, other discovery costs, and
other expenses, costs or fees paid or otherwise incurred by the prevailing party in connection with the Arbitration (including without
limitation in connection with the Appeal).

 

     

     

    

 

6.
   Miscellaneous.

 

6.1   Severability.
If any part of these Arbitration Provisions is found to violate or be illegal under applicable law, then such provision shall be
modified to the minimum extent necessary to make such provision enforceable under applicable law, and the remainder of the Arbitration
Provisions shall remain unaffected and in full force and effect.

 

6.2   Governing
Law. These Arbitration Provisions shall be governed by the laws of the State of Utah without regard to the conflict of laws principles
therein.

 

6.3   Interpretation.
The headings of these Arbitration Provisions are for convenience of reference only and shall not form part of, or affect the interpretation
of, these Arbitration Provisions.

 

6.4   Waiver.
No waiver of any provision of these Arbitration Provisions shall be effective unless it is in the form of a writing signed by the party
granting the waiver.

 

6.5   Time
is of the Essence. Time is expressly made of the essence with respect to each and every provision of these Arbitration Provisions.

 

[Remainder
of page intentionally left blank]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]